At Strongbridge Biopharma, our focus on rare diseases has resulted in a portfolio of innovative treatments for rare endocrine conditions, as well as the acquisition of the US rights to KEVEYIS.
At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.
The Strongbridge team is passionate about making a positive difference in the lives of patients with rare diseases. It’s why we’re here.
© 2017 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA™ is a trademark of Strongbridge Biopharma plc.
KEVEYIS® is a registered trademark licensed exclusively in the US to Strongbridge Biopharma plc.
MLR010 V7 12/2016